This document provides information on the composition, characteristics, pharmacology, pharmacokinetics, indications, dosage, and possible adverse reactions of Salcatonin Injection (brand name: Casimon).
This leaflet provides detailed information on Salcatonin Injection, a synthetic calcitonin peptide used for treating osteoporosis, hypercalcemia and Paget disease. It includes pharmacology, pharmacokinetics, indications, dosage regimens, contraindications, adverse reactions, and storage guidelines.
The product is supplied as a clear, colorless injectable solution (1 ml = 50 IU) in amber glass bottles (2 vials per box). It should be stored between 2 °C and 8 °C and used within 24 months of manufacture. All administration must be performed under medical supervision. This manual is written in Chinese.
| Active ingredient | Synthetic calcitonin peptide |
|---|---|
| Excipients | Sodium oxide, tocopherol, trihydrate acid, acetic acid |
| Molecular weight | 3431.89 |
| Appearance | Clear, colorless liquid |
| Dosage form | Injection, 1 ml = 50 IU |
| Storage temperature | 2 °C to 8 °C |
| Packaging | Amber glass bottle, 2 vials per box |
| Shelf life | 24 months |
The injection must not be used in patients allergic to calcitonin, nor in pregnant or lactating women.
Give 50–100 IU by intramuscular or subcutaneous injection once daily for the first week, every other day for the second week, then once weekly for weeks 3–12.